GGrantIndex
Sort

15,842 grants matching pancreatic cancer

TARGETING EXTRACELLULAR MATRIX-CANCER STEM CELL INTERACTIONS IN PANCREATIC CANCER

$334,832
William H Matsui · University Of Texas At Austin · R01 · FY2020 · CA

Core C: In Vivo Imaging, Dosimetry & Technology Transfer

$334,794
Brian William Pogue · Massachusetts General Hospital · P01 · FY2017 · CA

MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM

$334,731
Lewis C Cantley · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA

Transcriptional Regulators of Exocrine Pancreatic Development

$334,680
Raymond J. Macdonald · Ut Southwestern Medical Center · R01 · FY2012 · DK

Transcriptional Regulators of Exocrine Pancreatic Development

$334,680
Raymond J. Macdonald · Ut Southwestern Medical Center · R01 · FY2011 · DK

Molecularly guided multimodal theranostics for breast cancer

$334,627
Amit Joshi · Baylor College Of Medicine · R01 · FY2012 · CA

Acidic Phospholipid-Selective Treatment for Neuroblastoma

$334,587
Xiaoyang Qi · University Of Cincinnati · R01 · FY2011 · CA

Light-Triggered Drug Release in Primed Pancreatic Tumors

$334,565
Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2015 · EB

Phosphorylation-dependent regulation of GLI transcription factors

$334,562
Scott Atwood · University Of California-Irvine · R01 · FY2023 · CA

MODELS FOR GENETIC ASSESSMENT OF TUMOR MAINTENANCE GENES IN PDAC

$334,533
Tyler E Jacks · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

Tumor Antigens for Individual Signatures and Therapy

$334,502
Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2013 · CA

Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit

$334,466
Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2014 · CA

Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A

$334,432
Marc D Porter · University Of Utah · R33 · FY2012 · CA

Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity

$334,305
David C Linehan · University Of Rochester · R01 · FY2023 · CA

Analysis of the p53 in vivo using a unique mouse model

$334,263
Gerard Ian Evan · University Of California, San Francisco · R01 · FY2011 · CA

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

$334,251
Asfar S Azmi · Wayne State University · R37 · FY2024 · CA

Defining Secreted Glycan Alterations in Pancreatic Cancer

$334,160
Brian B Haab · Van Andel Research Institute · R33 · FY2008 · CA

Role of TGFBeta alterations in pancreatic cancer

$334,125
James Freeman · University Of Texas Hlth Science Center · R01 · FY2010 · CA

The Hippo Signaling Pathway in Pancreatic Cancer

$334,090
Anirban Maitra · Johns Hopkins University · P01 · FY2013 · CA

Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer

$334,075
Kenneth P Olive · Columbia University Health Sciences · R01 · FY2015 · CA

Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer

$334,075
Kenneth P Olive · Columbia University Health Sciences · R01 · FY2012 · CA

Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer

$334,075
Kenneth P Olive · Columbia University Health Sciences · R01 · FY2011 · CA

Investigation of the Cell-of-Origin and Cancer Stem Cells in Pancreatic Adenocarc

$333,989
Tyler E Jacks · Dana-Farber Cancer Inst · P01 · FY2009 · CA

Isolation Chemistry of Filamentous Fungi and Biological Evaluation

$333,984
Nicholas Hunter Oberlies · Ohio State University · P01 · FY2015 · CA

Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH

$333,963
Guang-Yu Yang · Northwestern University At Chicago · R01 · FY2013 · CA